Former NFL quarterback Boomer Esiason is the most visible national figure in the fight against cystic fibrosis, a life-threatening, genetic disease that affects the lungs and digestive systems of 30,000 children and adults in the United States.
Throughout his career in professional sports and the media, Esiason has been a committed and active participant in many charitable causes, but he began focusing on cystic fibrosis in 1993 when his son, Gunnar, was diagnosed with the disease.
In 1994, Esiason launched the Boomer Esiason Foundation, a dynamic partnership of leaders in the medical and business communities joining with a committed core of volunteers to heighten awareness, education and quality of life for those affected by cystic fibrosis, while providing financial support to research aimed at finding a cure. Since its inception, the Boomer Esiason Foundation has raised more than $90 million to support research toward a cure for CF, as well as programs directly benefiting the CF community.
As the median age of survival for CF patients has increased to more than 37, and many are living well into their adult years, Esiason has turned his focus to bridging the gap between pediatric and adult CF care. The Boomer Esiason Foundation has led the charge to create state-of-the-art facilities for those adults afflicted with the disease. This effort began when the Foundation granted Columbia University Medical Center $6 million to establish the Gunnar Esiason Adult Cystic Fibrosis and Lung Program -- a top adult CF care center that opened doors in 2009. Esiason and his Foundation have also instituted several educational, awareness and compliance programs aimed at the adult CF population.
Esiason continues to attack the disease head-on and helps bring CF to the forefront of policy discussions throughout the country. He has traveled to Capitol Hill on multiple occasions and to various states to speak on behalf of the CF community.
After an All-America career at the University of Maryland, Esiason enjoyed a 14-year career in the NFL as a quarterback for the Cincinnati Bengals, New York Jets and Arizona Cardinals. He became a four-time Pro Bowl quarterback and one of the most successful quarterbacks in NFL history, including being named the NFL's Most Valuable Player in 1988. Esiason ended his career with 2,969 completions in 5,205 pass attempts (57 percent completion percentage) for 247 touchdowns and 37,920 yards.
In 1995, the NFL honored Esiason with the Walter Payton Man of the Year Award in recognition of his excellence on the football field as well as his charitable work through the Boomer Esiason Foundation and other organizations.
Upon retiring from the NFL after the 1997 season, Esiason headed straight for the broadcast booth. He made his debut as a commentator for ABC's NFL "Monday Night Football" and called "MNF" games for two years. For almost two decades, he called games for Westwood One Radios' "Monday Night Football" broadcasts with Marv Albert, Howard David, Dave Sims and Kevin Harlan. Esiason joined CBS Sports in 2002 as a studio analyst for "The NFL Today," the CBS television network's NFL pregame show. In 2007, he debuted as host of WFAN's national weekday morning radio show, now called "Boomer and Gio." The show is simulcast nationally on the CBS Sports Television Network. Three years ago, Boomer added Showtime’s “Inside the NFL” to his media portfolio, as a co-host.
Esiason, and his wife, Cheryl, have two children, Gunnar and Sydney. They reside in Manhasset, NY.
Andy Slavitt has decades of private and public sector leadership in health care. Over his career, Andy has shaped some of the most significant and successful initiatives in health care impacting millions of Americans and the direction of the health care system. From 2015 to 2017 he served as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) under President Obama, overseeing the Medicaid, Medicare, the Children’s Health Insurance Program, and the Health Insurance Marketplace. Under his leadership, the U.S. health care system saw record reductions in the uninsured rate, nationwide improvements in quality, record low cost growth, and a major upsurge in value-based payment models.
Andy currently serves as Board Chair of United States of Care, a non-partisan non-profit dedicated to ensuring that all Americans have access to quality, affordable health care, and that policies to make progress toward that goal are politically feasible and fiscally responsible. Andy is also the senior partner in a venture firm focused on investments in the most under-served parts of health care. In addition, he is a Senior Advisor to the Bipartisan Policy Center, and co-Chairs the BPC's Future of Health Care effort, and serves on a number of health care boards.
Andy lives in Minnesota with his family. He is a graduate of the Wharton School and The College of Arts &
Sciences at the University of Pennsylvania, and received an MBA from Harvard Business School.
Michael R. Agostino, R.Ph., is the President of Amber Pharmacy, a provider of specialty pharmacy services throughout the nation. Amber Pharmacy is headquartered in Omaha, with satellite locations in Chicago, Dallas, Houston, Philadelphia and San Bernardino.
Mike is also President and a founder of Hy-Vee Pharmacy Solutions (HPS), a specialty pharmacy that provides services throughout the Midwest. HPS was one of the first specialty pharmacies in the nation to offer specialty services at retail locations.
Previous work includes serving as the Vice President, Pharmacy Innovation and Business Development for Hy-Vee and Vice President of Managed Care Sales for Walgreens.
Mike is extremely active in the pharmacy community. In addition to his participation in NASP, he is an instructor for the University of Nebraska Medical Center’s pharmacy program, an editorial board member for Specialty Pharmacy Times and the author of many published articles. He is also very involved in supporting non-profit, economic and community organizations, including serving on the Board of Directors for the Leukemia and Lymphoma Society.
Mike holds a Bachelor of Science Pharmacy Degree from Northeastern University.
Mr. Allinson is a seasoned leader with over 30 years of progressive managerial experience in many areas of pharmacy and healthcare operations. Mr. Allinson received his BS in Pharmacy degree from the University of Pittsburgh and his MS in Pharmacy Administration from The Ohio State University. He completed an administrative/clinical residency at Riverside Methodist Hospital. In addition, he has completed many executive courses in Hospital Administration, Quality Management, Finance, Purchasing and Inventory Control.
During his career, Mr. Allinson has held numerous senior management positions in hospital pharmacy, hospital administration and specialty pharmacy. He is Co-founder and Executive Chairman of Therigy a specialty pharmaceuticals consulting and health care informatics company.
Mr. Allinson is currently a clinical instructor/preceptor for the University of Florida, College of Pharmacy. He is a member of the Rho Chi Pharmacy Honor Society and received the Alumni of the Year award from the University of Pittsburgh School of Pharmacy in 1996; the Jack L. Beal Post baccalaureate Award from The Ohio State University, College of Pharmacy in 2008; and the Pharmacy Times Next-Generation Pharmacist Technology Innovator award for 2016.
Sheila Arquette is the Executive Director of the National Association of Specialty Pharmacy. She holds a Bachelor of Science degree in Pharmacy from the State University of New York at Buffalo School of Pharmacy. She has extensive practical and leadership experience in retail pharmacy, hospital pharmacy, long-term care consulting and dispensing, in addition to the managed care, PBM and specialty pharmacy space. She is a regular speaker and participant at national pharmacy conferences, roundtables and industry meetings.
Sheila comes to NASP from Independent Health where she was the Director of Pharmacy Services.
Sheila has served on the NASP membership committee and as the co-chair of the Government Affairs Committee. She was elected to the NASP Board of Directors and received the NASP Distinguished Service Award in September 2016. She also is a long- standing member of AMCP.
Ryan J Atkinson, PharmD, MBA, is the Senior Director of Specialty Pharmacy Strategy for Maxor National Pharmacy Services. Dr Atkinson has over 17 years of specialty pharmacy, managed care, and development experience. His expertise in disease management and in-depth knowledge of formulary development and maintenance, industry cost and clinical trends, specialty pipelines, and other managed care topics enables him to ensure patients receive medically sound, cost-effective care. He attended Butler University in Indianapolis, IN, where he earned a Doctor of Pharmacy and a Master of Business Administration.
Jeffrey S. Baird, Esq., is Chairman of the Health Care Group at Brown & Fortunato, P.C., a law firm based in Amarillo, Texas. Mr. Baird represents pharmacies, HME companies and other health care providers throughout the United States. He works closely with governmental agencies. Mr. Baird has authored numerous articles and is a frequent lecturer throughout the country. He serves on the Medtrade Education Advisory Board and the AAHomecare Regulatory Council. Mr. Baird earned a B.B.A. from the University of Iowa and received his law degree from the University of Tulsa College of Law. Mr. Baird is Board Certified in Health Law by the Texas Board of Legal Specialization.
Natalie leads the National Channel Account Team, as part of the US Market Access organization. Her team is accountable for distributors, retailers, specialty pharmacies, oncology group purchasing organizations and dialysis organizations for products across the AstraZeneca portfolio. Natalie’s role is focused on developing channel strategies from distribution to the point of dispense across all of AZ’s therapeutic areas – Oncology, Respiratory, Cardiovascular Metabolic and Renal – and partnering with customer across all channel segments to ensure patient access to AZ medicines.
In her current role at Biologics by McKesson, Paula works to expand access and affordability for oncology and complex care therapies while also implementing payer solutions that drive optimal outcomes, effective risk management and cost-effective patient care. In her 10-year career with Biologics, Paula has also served as the VP of Clinician Services managing the provider-facing sales team responsible for ensuring service excellence to physicians, their clinical support teams and, most importantly, their patients who needed oral therapies and specialty pharmacy support.
Throughout her more than 25 years in managed care, sales and physician practice management, Paula has focused on developing provider networks for managed care plans and academic medical centers. She also founded and managed a consulting firm that provided physician practice management services including payer contract negotiations, technology implementation, revenue cycle management and employee professional development.
Rebecca Bigler earned her PhD in Genetics and Molecular Biology from The University of North Carolina at Chapel Hill with a focus on molecular neurobiology of synaptic plasticity in the mammalian central nervous system. Dr. Bigler has diverse scientific work experience in industry and in academia and a broad knowledge base in molecular, cellular and neuro- biology. She currently serves on the Board of Directors of the Specialty Pharmacy Certification Board as the Education Director and as the Chief Scientific Officer of Therapeutic Genetics Consulting Associates, a firm specializing in closing the knowledge gap between cutting edge genetic medicine and routine medical and pharmacy care.
Nick Calla, RPh is the Vice President Pharma Relations for BioMatrix Specialty Pharmacy, LLC. He has responsibility for the development of the relationships with the manufacturer community as it relates to products within their specialty portfolio. Prior to BioMatrix, Nick was the Vice President of Industry Relations for Cardinal Health Specialty Pharmacy division, a part of Cardinal Health Specialty Solutions. He had responsibility for the development of contracts and programs with the pharmaceutical industry as it relates to products within their specialty portfolio. Nick was also Vice President of Trade Relations for Community Specialty Pharmacy Network. He had the responsibility of business development as well as maintenance of the relationships with manufacturers around the country as it relates to access to particular products as well as the clinical programs designed to support those products. Nick also performed the same duties for Walgreens Specialty Pharmacy for 7 years in developing relationships with the manufacturing community on behalf of the specialty pharmacy.
Prior to Walgreens, Mr. Calla worked as Director of Clinical Programs and Network Administration for Eckerd Health Services. Mr. Calla was also President and General Manager of Oncology Pathways, which was a group purchase organization founded by the UPMC Cancer Center and Medmark Specialty Pharmacy. Therefore, Mr. Calla has experience working with both pharmaceutical manufacturing and retail pharmacy community and has also participated in several pharmacy and therapeutics committees.
Nick is a member of the National Association of Chain Drug Stores, Academy of Managed Care Pharmacy and is a Board Member of the National Association of Specialty Pharmacy. Nick is the past president of the Specialty Pharmacy Certification Board. Nick has expertise in the area of compliance, disease management, intervention programs, and in the area of negotiations with providers for a network. Nick received his bachelor’s of pharmacy degree from the University of Pittsburgh. Nick also received a Juris Doctorate from Duquesne University. In addition, Nick has completed fellowship programs at the University of Pennsylvania, University of Southern California and Harvard University.
Linda Clark is a nationally recognized litigator and chair of Barclay Damon's Health Care Controversies Practice Area. In the health care arena, Linda is a trusted advisor to health care providers, pharmaceutical companies, and pharmacies nationwide with regard to the resolution of high-stakes litigation disputes and government investigations and prosecutions. She represents health care professionals and entities in administrative proceedings, hearings, and appeals before various federal and state regulatory and prosecutorial agencies. Linda has handled a wide range of high-profile network termination, payer, and false claims cases across the country, including in Hawaii, Texas, Missouri, and Florida.
Linda's practice also focuses on complex multi-party litigation. Over the past two decades, she has served as lead litigation counsel as well as national, regional, and local counsel in a diverse range of matters such as the prosecution and defense of claims brought in state and federal courts on behalf of large groups of business and institutional clients, including New York's sprawling failed trust litigation in which Linda represented over 170 health providers facing massive state assessments of hundreds of millions levied by the state.
Linda was one of two recipients of the 2017 Shira A. Scheindlin Award for Excellence in the Courtroom, given by the New York State Bar Association to two leading women litigators in the state. She was selected to the Top 100 "Super Lawyers" in New York State in 2017, listed in The Best Lawyers in America for five consecutive years, and selected to Super Lawyers in business litigation and health care for eight consecutive years.
She is a frequent lecturer, organizer, and contributor of written materials at accredited national, regional, and local continuing legal education programs for attorneys. Additionally, Linda is a former president of the Capital District Women's Bar Association and a founding member of Barclay Damon's Diversity Committee.
Charles (Chuck) Collins, MS, MBA, is the President of Healthcare Stakeholder Solutions™ LLC, a managed market consultancy in its 7th year focusing on the healthcare delivery disparities across multiple therapeutic areas such as oncology, hematology, rheumatoid arthritis, hyperkalemia, obesity, diabetes, multiple myeloma, anaphylaxis prevention, bleeding disorders, vaccines, and chronic non-cancer pain. With a deep industry network, Healthcare Stakeholder Solutions works across all managed market channels and partners with various healthcare delivery organizations to develop customized managed market solutions. Mr. Collins has over 29 years of career experience in the life sciences industry and brings a vision of multidisciplinary expertise and stakeholder alignment to the organization. Mr. Collins serves as a Senior Consultant to multiple clients. Mr. Collins also serves as a Senior Fellow to Medonomics, a nonprofit, nonpartisan think tank specializing in health policy, finance, and operations.
Mr. Collins graduated with a bachelor’s degree in chemistry from Virginia Commonwealth University. Mr. Collins additionally holds a master’s degree in clinical chemistry from Old Dominion University and a master’s degree of business administration in pharmaceutical marketing from Saint Joseph’s University in Philadelphia.
Amy Cotton Peterson is chair of Quarles & Brady's Health Law Practice Group. As a licensed physical therapist and health care attorney, she has a unique perspective on issues that face health care providers and entities. Her practice focuses on health care transactions, regulatory and compliance issues, business development and provider defense.
Nancy began her career in pharmacy in 1987 after graduating from the University of Texas, Austin. She owned and operated Royse City Pharmacy in Royse City, Texas from 1992 until 2014. Nancy has been a part of Senderra Specialty Pharmacy since 2015 when she joined their clinical pharmacist team. She transitioned into operations and is currently Vice President of Operations.
Since joining ReCept in 2009, Carmine has been responsible for overseeing ReCept’s long term national growth, developing a multi-disciplined team focused on patient care, and integration of strategic initiatives to expand specialty pharmaceutical care to large health systems.
With more than 30 years of executive leadership in both retail and specialized pharmacy services, he was a key industry contributor in defining the “specialty” pharmacy model. Prior to joining ReCept, Carmine served as Chief Operating Officer for TheraCom, a service division of CVS Caremark, and Vice President of CVS Caremark Specialty Operations, overseeing all specialty retail locations across 25 states. Mr. DeNardo earned a BS in Pharmacy from Northeastern University in Boston, Massachusetts
Martin ("Marty") Robert Dix is Board Certified by The Florida Bar in Health Law and practices with Akerman LLP in Tallahassee, Florida. He is a member of the firm's Health Care Practice Group, its HIPAA Committee, and its Cannabis Practice. He is on the Board of Directors of the American Society for Pharmacy Law (ASPL) and has been a member of ASPL since 1997.
Mr. Dix handles regulatory and transactional legal issues for clients involved in the legal drug distribution and delivery system. He represents clients on a variety of pharmacy and drug distribution licensing, disciplinary, reimbursement, transactional and health care regulatory issues. Mr. Dix represents two chain pharmacies on all Florida Board of Pharmacy disciplinary cases and has represented clients before the Board of Pharmacy since 1988. He also represents eight Florida hospital systems (primarily on pharmacy and drug distributions issues), two drug manufacturers, several drug and veterinary drug wholesalers, and a variety of other providers and entities. He regularly handles matters before the Florida Board of Pharmacy, the Florida Division of Drugs, Devices and Cosmetics, the Agency for Health Care Administration as well as federal drug, health care and privacy agencies.
Jesse C. Dresser, Esq. joined Frier Levitt in 2010 and has been with the firm since graduating magna cum laude from Seton Hall University School of Law. Since that time, Jesse has developed a thorough knowledge of State laws as they pertain to pharmacy practices, insurance billing practices, and PBM regulation. In addition, Jesse routinely lectures to compounding, specialty and retail pharmacies regarding a variety of topics, including proper submission of claims to insurance companies, compliant pharmacy and compounding practices, and methods of growing a pharmacy business while avoiding scrutiny from both payors and regulators. Through his experience with the Pharmacy Law team, Jesse has developed an in-depth knowledge of the Food, Drug and Cosmetic Act and its implementing regulations. Jesse has represented numerous clients in connection with audits, network admission efforts, and network terminations. Jesse regularly communicates on behalf of pharmacies with management and general counsel for numerous pharmacy benefit managers (PBMs) and insurance companies.
In addition to his work with pharmacy clients, Jesse also represents a variety of other entities including other healthcare providers, pharmaceutical manufacturers, healthcare technology companies, and wholesalers. Through this work, Jesse has focused on the intersection between the law and economic considerations, including drug pricing, marketing techniques, and benefits management. Jesse is a Partner in the Pharmacy Law Group with a focus on payor issues and litigation.
Simone Colgan Dunlap is national chair of the Quarles & Brady's Health & Life Sciences Industry Team and leads the firm's Specialty Pharmacy team. Simone's practice is focused on regulatory compliance, related risk management, and corporate/contracting matters for a variety of clients, with a particular emphasis on specialty pharmacy. Simone provides practical and strategic advice to clients on a diverse array of regulatory compliance issues including HIPAA, state privacy laws, AKS, CMP and state pharmacy laws. She also has significant experience drafting and negotiating agreements including distribution agreements, BAAs, GPO agreements, data use agreements, licensing agreements, specialty pharmacy services agreements, HUB agreements, marketing agreements, Risk Evaluation and Mitigation Strategies (REMS) consulting agreements, independent contractor agreements, and numerous other commercial contracts. Simone was recognized as a Southwest Super Lawyers® Rising Star in Health Care in 2017 and 2018. She graduated cum laudeM/i> from the University of Michigan Law School in 2008.
Lily Duong, Chief Clinical Officer, is responsible for the development of Therigy’s drug therapy management program and clinical reporting. Lily provides clinical expertise and oversees the team that develops custom clinical and adherence programs, as well as adherence metrics and outcomes reports for different patient populations and various disease states.
Before joining Therigy in 2013, Lily held a variety of positions at Express Scripts, including Senior Director of Clinical Operations, Senior Director of Pharma Account Management, and Senior Director of Clinical Business Development. She also served on Express Scripts’ Therapeutic Assessment Committee.
Lily received both her BS and Doctor of Pharmacy degrees from Temple University School of Pharmacy and completed residencies at hospitals and clinics in New Jersey and New York City. She also holds a BS in chemical engineering from Drexel University and has provided English-Vietnamese interpretation services for patients at the Hospital of the University of Pennsylvania.
Elizabeth Duruz is the Director, Clinical Program Service, Pharmacy providing policy and procedure creation, update, and review; patient adherence program development and oversight; CPR+ clinician training; comprehensive review of new therapies added to formulary; and involvement in the Performance Improvement team. She has been a pharmacist for nineteen years with experience including hospital, long-term care, and mail order pharmacy.
Elizabeth has ten years of experience in specialty pharmacy with BioRx/Diplomat Specialty Infusion Group. During this time she has gained knowledge in hereditary angioedema (HAE), hemophilia, Alpha1-antitrypsin deficiency, intravenous and subcutaneous Immunoglobulin (both neuro and PIDD diagnoses), as well as other medications used to treat rare conditions.
Ms. Duruz received her Bachelor in Business Administration degree from University of Cincinnati in 1992 where she majored in Marketing. In 2000, Elizabeth received her Bachelor of Science degree in pharmacy from University of Cincinnati. In April 2016, she obtained her Certified Specialty Pharmacist (CSP) credentials. Elizabeth currently serves on the Pharmacist Steering Committee for IgNS and is a board member for Specialty Pharmacy Certification Board (SPCB).
Ron Friedman is a shareholder at Karr Tuttle Campbell, LLC in the Pacific Northwest assisting pharma and health care clients in federal and state actions and proceedings -- civil, criminal, and administrative, and with compliance. Prior to entering private practice, Ron served as a federal prosecutor in Seattle for 22 years concentrating in the pharma sector. Ron is a graduate of the Harvard Law School.
Ron Friedman is a shareholder at Karr Tuttle Campbell, LLC in the Pacific Northwest assisting pharma and health care clients in federal and state actions and proceedings -- civil, criminal, and administrative, and with compliance. Prior to entering private practice, Ron served as a federal prosecutor in Seattle for 22 years concentrating in the pharma sector. Ron is a graduate of the Harvard Law School.
Jessie Heaton, PharmD, is Vice President of Specialty and Infusion for Maxor. He earned a Doctor of Pharmacy degree in Lubbock at Texas Tech University Health Sciences Center, and is a Registered Pharmacist in Texas and 18 additional states. He serves as an adjunct faculty for home infusion and specialty pharmacy services through Texas Tech University Health Sciences Center School of Pharmacy.
Jessie has worked in home infusion and specialty pharmacy for over 11 years with Maxor National Pharmacy Services (MNPS) family of companies, and has 20 years of pharmacy experience. He has directed Pulmonary services through Maxor Specialty that serves a large number of patients living with Cystic Fibrosis/Bronchiectasis nationwide as well as home infusion therapies. He has extensive knowledge of accreditation and regulatory requirements for clinical specialty and infusion pharmacy services. In addition, he works closely with rare and orphan drug manufacturers regarding limited drug distribution program implementation and management.
Michael Hess leads the firm's Specialty Pharmacy & Pharmaceuticals Practice Group. His ability to balance legal issues with business issues has earned him a reputation as a go-to lawyer in the specialty pharmacy industry.
His practice involves a range of legal counseling for leaders in the pharmacy industry, including:
Lindsay Holmes focuses her practice on regulatory and transactional matters, primarily in the healthcare and life sciences industries. She has experience advising clients on Food and Drug Administration (FDA) regulatory matters, including food, drug, device, dietary supplement and cosmetic issues, as well as matters related to 503B outsourcing facilities operating pursuant to the Drug Quality and Security Act (DQSA), and entities subject to the Drug Supply Chain Security Act (DSCSA). She also has experience assisting clients with matters related to the U.S. Department of Agriculture (USDA) and Drug Enforcement Agency (DEA) compliance. In addition, Lindsay helps pharmacy, wholesaler and third-party logistics provider clients navigate state licensing and pharmacy practice act issues. Her background also includes counseling clients on data privacy and security matters, fraud and abuse, and Medicare Part D.
John W. Jones, Jr. is a partner and chair of the Health Care Transactions and Regulatory Practices and a member of the Leadership Team of the Health Sciences Department of Pepper Hamilton LLP, resident in the Philadelphia office. He is a past member of the firm's Executive Committee. Additionally, he leads the firm's Pharmacy, Supply Chain, Group Purchasing and Buying Cooperative Practices, Acute Care and Hospitals and Health Systems Practices, Physician Practice Management, and Long-Term Care Organizations and Post-Acute Industry Practices, and is a member of the White Collar and Corporate Investigations Practice Group.
Mr. Jones concentrates his practice in corporate and health care matters. He represents specialty, retail and institutional pharmacies, as well as pharmaceutical, medical device, biotech companies, providers and suppliers on a wide range of regulatory issues including fraud and abuse, supply chain, and compliance pre-and-post product launch. He has significant experience in nonprofit and for-profit health system affiliations, member substitutions and strategic transactions.
Dr. Cory Kidd is the founder and CEO of Catalia Health, a patient care management company. The company develops a hardware and software platform that uses a combination of psychology and artificial intelligence to engage patients through interactive conversations. These conversations happen through mobile, web, and interactive robotic interfaces; together these interfaces create a relationship that can reach patients at any time they need support. The data reported back through the system gives Catalia Health’s customers valuable information to understand the daily activities and needs of their patients.
Dr. Kidd is a serial entrepreneur who has been working in healthcare technology for nearly two decades. He received his M.S. and Ph.D. at the MIT Media Lab in human-robot interaction and his B.S. in Computer Science at the Georgia Institute of Technology.
Ron Lanton III, Esq., has over 25 years of experience in government affairs at the municipal, state, and federal government levels, with 15 years dedicated to the healthcare sector. He is currently the executive director and head lobbyist at Frier Levitt Government Affairs, LLC and senior counsel at Frier Levitt. He frequently consults Wall Street firms on financial issues related to the healthcare sector.
Ron is a featured industry speaker on issues such as pharmaceutical safety and healthcare cost containment, and he has authored numerous articles regarding pharmacy and healthcare law. He is a regular contributor to Specialty Pharmacy Times, the Center for Biosimilars and Biosimilar Development. He earned a B.A. from Miami University and a J.D. from The Ohio State University. He is also the chair of the Biologics Committee for the New York Bar Association. Ron has been admitted to practice law in New York, the District of Columbia and Illinois.
Jonathan E. Levitt, Esq. co-founded the boutique healthcare law firm of Frier Levitt, LLC in 2000. With over thirty attorneys, Frier Levitt has a national presence in Life Sciences, Pharmacy Law and Healthcare Law, and has been counsel to multiple nationwide class actions of independent pharmacies. In addition to featuring multiple industry thought leaders, Frier Levitt's growing rank of attorneys has numerous clinicians with years of hands-on experience, including multiple pharmacists, a registered nurse, a physician's assistant, and a podiatrist. After graduating from Rutgers College, Rutgers University, Jonathan pursued a Juris Doctorate degree from New York Law School, where he edited the New York Law School Law Review and graduated cum laude.
At Frier Levitt, Jonathan has dedicated his practice to representing pharmacies and in-office physician dispensers nationally regarding federal and state healthcare laws and regulations, audits and appeals, and corporate transactions. Jonathan advises public companies in the Pharmaceutical, Pharmacy and Wholesaler spaces on Regulatory, Transactional and Litigation Issues. Jonathan regularly speaks at pharmacy and physician conferences across the country in an effort to share his firm's specialized knowledge. In addition to lecturing, Jonathan has been published in internationally-circulated publications and commits himself to pro bono and public service assignments. He is also the author of the LinkedIn Group "Hot Topics in Pharmacy Law."
For the last 12 years, Jonathan's peers have elected him as a Super Lawyer. Jonathan is Certified by the Supreme Court of New Jersey as a Civil Trial Attorney. Jonathan has competed in triathlons, including the 2012 New York Ironman U.S. Championships, and also trains in Brazilian Jiu Jitsu.
Kathy Lewis is a health care and technology leader with over 30 years of experience leveraging IT, electronic health records and clinician workflow to drive clinical improvements, organizational change, and business value. At Surescripts, Kathy is responsible for specialty medication product strategy and execution, business direction for the accelerator technology platform, and the company’s participation in Carequality.
Doug Long is Vice President of Industry Relations at IQVIA (formerlyQuintilesIMS) one the world’s largest pharmaceutical information company. IQVIA offers services to the pharmaceutical industry in over 101 countries around the globe.
Doug has been with IQVIA since 1989. His fundamental task is to help secure data for all existing and new databases supported by IQVIA, manage supplier, manufacturer & association relationships, and develop information for data partners. As direct consequence of his involvement in these areas, Doug has considerable experience with, and a unique perspective on, the changing U.S. and global healthcare marketplace and pharmaceutical distribution.
Doug is a frequent Industry speaker for the following groups: Health Distribution Management Association, National Association of Chain Drug Stores, Food Marketing Institute, National Council of Prescription Drug Programs, Pharmaceutical Care Management Association, National Community Pharmacist Association, International Federation of Pharmaceutical Wholesalers, Generic Pharmaceutical Association, BIO, AMCP, PhRMA, HSCA and many others. Doug was the opening speaker at the 2015 HHS Pharmaceutical Forum on Innovation, Access, Affordability & Better Health. His topic was the balance between Innovation and Smarter Spending.
Doug is the recipient of the 2016 IFPW Leadership Award. This award is given to an industry leader who has demonstrated a commitment to international collaboration and information sharing to assist IFPW on its mission to help members and stakeholders advance the safe, efficient and continuous access to pharmaceuticals worldwide through the promotion of good distribution practices and services.
Doug also received the distinguished NACDS “Harold W. Pratt Award” in 2011 which recognizes individuals whose activities have contributed to the promotion, recognition and improvement of the practice of pharmacy within the chain drug industry. NACDS President and CEO Steven C. Anderson, IOM, CAE, stated,
“Doug Long has earned a reputation as one of the foremost ‘go-to’ sources when it comes to the numbers and trends behind this industry. He has built a reputation of synthesizing the latest industry information and forecasting ‘what’s next’ in ways that helps stakeholders to understand what it means for their day-to-day businesses.”
Prior to receiving the Pratt Award, Doug was honored with the HDA NEXUS Award for lifetime achievement in 2004, the IMS prestigious Summit Award in 2003 and the IMS CEO Team award in 2013. He was also honored recently with the NCPDP Champion award for 2019. Before joining IMS Health Doug held positions at Nielsen Market Research for sixteen years in various sales and marketing capacities. A native of Illinois, Doug received a BA from DePauw University and holds an MBA in Management from Fairleigh Dickinson University in New Jersey.
Meetings & Conventions magazine lists Allison Massari as one of the top 10 best speakers for “motivation” in the United States. She teaches the secrets she discovered to triumph despite tragedies, thrive in turbulent times, and forge your own path to success. Allison is a trusted business coach, personal development expert, international speaker and artist. She has been featured on ABC News, NBC, FOX, and in Family Circle Magazine.
Allison assists people at deep levels, equipping them with tools to better manage their lives, to be in the world vital and grounded. She has become a fiery voice for the potent power of compassion, kindness, and indestructible perseverance.
Massari’s professional career began with diverse achievements as an entrepreneur. She created four successful businesses over the course of 25 years. It began with a thriving fine arts business and jewelry line, Massari Fine Arts, LLC. Among her accolades were commissions for Fortune 500 companies including Lockheed Martin, General Mills and US Airways. With characteristic vigor, she launched her coaching and speaking career. Within months she was coaching CEO’s, and was preparing to appear in an international documentary focused on overcoming challenges. Within a year and a half, she was invited to give a TEDx talk in Spain on “The Future of Happiness”. And within two years she was voted the “#1 Rising Star in Speaking” by the National Speakers Association, and was traveling internationally, speaking and coaching full-time.
Her more serious credentials come from her life experience. Allison Massari found peace, purpose, and happiness after overcoming two extraordinary personal tragedies. In 1998, she survived a 60 mph car crash where she was trapped and burned alive; conscious the entire time. Just three years later she was hit again at 60 mph and sustained a closed-head brain injury. Allison has always believed in the miraculous. Her fiery determination and the love of family and friends helped bring her to a full recovery years later. She says, “I didn’t want to just heal. I wanted to feel peaceful. I became relentless in my pursuit to find the answers to life and to master it in totality.” The triumph of her physical and emotional recovery inspired Allison to propel her business to pinnacle achievements. She revived her art business with a 100% increase in sales and was awarded placement in the permanent collection of the Museum of Fine Arts in St. Petersburg, FL.
Allison has dedicated her speaking career to wellness, well-being, change, adversity and success– inspiring people with tools to more effectively manage their lives. Her mission is to bring transformation to individuals, businesses and communities. She also enjoys delivering keynotes to healthcare audiences for CE credits – to heal burnout in medical workers and to enhance patient-centered care. Her message focuses on the power of the human connection. In her own words, “Compassion heals the places that medicine cannot touch.”
As a sought-after private coach, her highly effective methods have enabled her to form bonds as a trusted confidante to CEOs, executives and entrepreneurs. Allison captures the hearts of audiences and clients as she demonstrates how to move forward with speed and grace. She is one of ten people in the world chosen to teach how to successfully overcome challenges in the international documentary film “ReSolve” by Polaris Global (release date soon). The film is hosted by the Head of Special Forces for the U.S. Military in Afghanistan and focuses on solutions to come through post-traumatic stress. Massari is also the founder of revolutionary programs for teenagers with severe burn injuries that continue to transform young people’s lives at the Adaptive Sports Center in Crested Butte, Colorado.
“I’ve come to a place where my heart pounds with excitement instead of fear. I learned how to transform my pain and how to take control of my life. If I could do this with my own life and under such extreme circumstances…imagine what you can do with yours.”
Allison holds a Masters of Arts degree from School of Visual Arts in New York City and a Bachelor of Arts from the Rhode Island School of Design, as well as being the recipient of an adventurous award to study in Brugge, Belgium and La NaPoule, France.
Roger Morris is the national chair of Quarles & Brady's Health & Life Sciences Industry Team, former chair of the firm's Health Law Practice Group, and a member of the firm's governing Executive Committee. His practice focuses on the representation of pharmacies, including retail pharmacies, pharmacy wholesalers, specialty pharmacies, compounding pharmacies, mail order pharmacies, veterinary pharmacies, pharmacy benefit managers (PBMs), and pharmacy manufacturers. He also represents health care providers, including hospitals, health systems, and medical staff.
Roger's previous career as a pharmacist enables him to provide unique insight to clients on a wide range of issues, including licensing new pharmacy locations, responding to regulatory inquiries and investigations before state review boards, and the development of complex new programs that include multiple points in the pharmacy distribution process and multi-state jurisdictional matters.
With a background as a defense, regulatory, and registered patent attorney who has also worked as a registered pharmacist, Lee Rosebush provides his clients with legal counsel that is grounded in first-hand experience. Whether his clients are confronted with legal issues related to the naming of a drug, clinical trials, marketing, promotions, or advertising, Lee possesses a strong understanding of the pharmaceutical industry which, combined with his attention to detail and experience working with biologics, medical device, and healthcare companies, gives clients a single source for regulatory and litigation counsel. With post-graduate degrees in finance and business, Lee is frequently sought out to help expedite corporate deals involving healthcare entities. He also advises private equity and public and private companies in due diligence matters and buy-sell transactions.
Lee's ability to smoothly shift between the legal, governmental, and pharmaceutical environments further helps him to efficiently secure operating licenses or assist drug manufacturers avoid compliance actions from governmental agencies. Active with the Drug Quality and Security Act (DQSA), as well as the Federal Food and Drug Administration's (FDA) regulation of pharmacy compounding, Lee speaks and writes on both issues, and is passionate about orchestrating and advocating for pharmacists and pharmacies. Additionally, Lee is Leader of BakerHostetler's Pharmacy and Reimbursement team and Co-Leader of the FDA, Products Promotion, and Defense team.
Tim Safley has more than three decades of experience in the healthcare profession, including twenty-five years in the pharmacy industry. Tim was the Regional Vice President for a national home care company and his leadership includes the Infusion, Specialty and HME markets. He was instrumental in helping to add specialty standards to the ACHC Pharmacy Program in early 2001. As this industry evolved he was able to adapt these standards to address payer requirements in the ever-changing healthcare sector.
Tim has a great track record of working with payers and PBMs to help tackle the need for both patient monitoring and cost containment within the specialty industry. He led the initiative to release the accreditation in the Distinction Program at ACHC. These distinction programs set companies apart as being specialists in their field of care such as Oncology and HIV. He is constantly working to address the needs of ACHC accredited pharmacies.
Dr. Smerker, Senior Director, Rare Markets at PANTHERx plays a critical role in the prospecting, qualification, and close new business. He has served in a variety of leadership positions with increasing responsibility for both specialty and community pharmacy organizations as well as written numerous articles on specialty pharmacy topics. He is as a point of contact for manufacturer trade relations and brand teams to serve as a subject matter expert on PANTHERx capabilities and services. Smerker contributes to the capabilities narrative raising the profile of PANTHERx, sets short and long-term business development strategies against company-wide targets, and actively identifies a new business pipeline.
He holds extensive experience in trade relations, business development, account management, specialty pharmacy contracting, and exclusive/semi-exclusive product launch strategy across a variety of rare disease therapeutic areas. He earned his PharmD. degree in 2009 and Master of Science in Pharmacy Business Administration (MSPBA) degree, an executive-style program designed for leaders in the business of medicines, in 2016 from the University of Pittsburgh.
Lee Ann Stember is president & CEO of NCPDP, a not-for-profit multi-stakeholder forum for developing healthcare business solutions, including ANSI-accredited standards for electronic exchange of healthcare information. As president & CEO for nearly four decades, she has led NCPDP to continued success in its transformative role in pharmacy services, creating and promoting adoption of consensus-based standards and best practices that improve patient safety and decrease costs.
Stember represents the Council and work of its membership to government agencies, other standards development organizations, healthcare industry associations and coalitions seeking to achieve HIT interoperability and other reforms that improve the coordination and quality of care while reducing system costs. She currently serves on the board of the Workgroup for Electronic Data Interchange (WEDI), the CAQH/CORE Advisory Board, and the boards of the MedData Foundation and the NCPDP Foundation. She is a member of the American Management Association (AMA) and the American Society of Association Executives (ASAE) as well as numerous healthcare organizations, including the Academy of Managed Care Pharmacy (AMCP), National Association of Chain Drug Stores (NACDS), National Community Pharmacists Association (NCPA), American Pharmaceutical Association (APhA),American Society of Health-System Pharmacists (ASHP), American Society of Consultant Pharmacists (ASCP), and Healthcare Information and Management Systems Society (HIMSS).
Stember has a Bachelor of Science degree from the University of Arizona College of Business
Jonathan L. Swichar focuses his practice in the area of commercial litigation and is an active trial lawyer, handling, across the United States, matters involving complex commercial disputes, securities law, shareholder disputes, white-collar criminal defense and investigations, insurance defense, healthcare litigation, healthcare fraud defense and internal corporate investigations. Mr. Swichar regularly counsels international corporations and has been lead counsel in hundreds of disputes in state and federal courts as well as in arbitrations and mediation.
Mr. Swichar is co-chair of Duane Morris' Pharmacy Litigation Group. He regularly represents healthcare providers in the investigation and defense against healthcare-related offenses in regulatory, civil and criminal proceedings. He also represents numerous healthcare providers, including pharmacies, throughout the United States in disputes with insurance companies and pharmacy benefit managers. Specifically, Mr. Swichar represents such providers in connection with, among other things, violations of non-compete agreements, issues in gaining entry into an insurance network, attempts by insurance companies/pharmacy benefit managers to terminate providers from such networks, reimbursement disputes and refusals by insurance companies/pharmacy benefit managers to abide by state any willing provider laws.
Mr. Swichar is active in a leadership capacity in several community and civic organizations. Admitted to practice in Pennsylvania and New Jersey, Mr. Swichar is a member of the Pennsylvania and Philadelphia bar associations. Mr. Swichar is a 1997 graduate of Temple University School of Law, where he was a member of the Temple Law Review, and a graduate of the University of Maryland.
Ray Tancredi is divisional vice president, Specialty Pharmacy Development Brand Rx/Vaccine Purchasing, at Walgreens, based in Deerfield, Illinois
Tancredi oversees a team responsible for all specialty pharmacy trade functions including Specialty Pharmacy product access, including limited distribution and relationships, managing manufacturer hub services and referrals, contract negotiation, implementation and compliance, pharma programs and services, data analysis and reporting, RFP support and coordinating clinical, patient services, new drug in-services, and education. Additionally, he oversees management of strategic manufacturer accounts in an effort of maximize contracts and provide exceptional customer service.
Tancredi also oversees the team responsible for brand prescription drug launches and vaccine procurement including flu vaccine, GPO relationships, and specialty pharmacy distributors.
EDUCATION: Tancredi earned his Bachelor of Science in Pharmacy from Temple University School of Pharmacy (1983) and is a registered pharmacist in PA and FL. He also holds a Master of Business Administration in Management from Eastern University (2001).
PROFESSIONAL MEMBERSHIPS: He is president of the Specialty Pharmacy Certification Board (SPCB) and is a Certified Specialty Pharmacist (CSP Certificate 032).
Bradley A. Wasser, Esq is an associate with the law firm Duane Morris, LLP. Mr. Wasser practices in the area of litigation with a focus on health care, private antitrust and business counseling and government advocacy. Mr. Wasser has experience with providing a wide range of legal, regulatory and business advice for national associations of health care providers, individual health care providers and pharmacies, beer wholesalers, retailers, and high technology firms.
Mr. Wasser is a member of Duane Morris' Pharmacy Litigation Group. He represents healthcare providers, including pharmacies, in disputes with insurance companies and pharmacy benefit managers ranging from audits, to network participation rights, to termination of providers from insurance and pharmacy benefit manager networks.
Mr. Wasser is a 2010 cum laude graduate of the University of Baltimore School of Law and a graduate of the University of Delaware.
Shannon Wiley, Esq is an attorney at Bass, Berry & Sims' Memphis office. Her practice focuses on healthcare regulatory matters with a specific emphasis in the specialty pharmacy industry. She advises clients on regulatory matters arising in pharmaceutical trade and distribution, such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, and FDA regulations such as the Drug Supply Chain Security Act. Additionally, she assists clients with the development, drafting and negotiation of agreements related to various components of the drug supply chain, such as limited distribution networks, pharmacy services agreements, and hub arrangements. Shannon also provides guidance on mergers and acquisitions.
Julie serves as a leader in business development for Amber & Hy-Vee Pharmacy Solutions (HPS), an independent provider of specialized pharmacy services nationwide. Amber and HPS are headquartered in Omaha, NE with multiple satellite locations across the US. Julie joined Amber in January 2012.
Julie leads the Trade Relations team at Amber & HPS and has built established relationships with key stakeholders throughout the specialty pharmacy and pharmaceutical manufacturer industry. She ensures Amber and HPS are at the forefront of industry trends and prepared for new medication launches.
Julie holds a Bachelor of Science in Medical Technology from the University of Nebraska Medical Center. She has over 20 years within the pharmaceutical world working for The Upjohn Company, Pfizer and then EMD Serono gaining experience in sales, account management and sales training. She enjoys tennis, has developed an interest in soccer and is highly interested in travel and other cultures.
Ms. Krista Zodet serves as President of the HealthWell Foundation. Ms. Zodet is responsible for developing the long-term direction of the organization in collaboration with the Board and providing strategic leadership and oversight of the organization’s operations, programs, and staff.
Ms. Zodet has been a valuable member of the Foundation’s management team since 2005 and has over 20 years of experience in the life sciences primarily focused on patient assistance and access to care.
Ms. Zodet received a Master’s in Social Work and a B.A. in Sociology from the University of Michigan, Ann Arbor.
*Subject to change